EUVIMEDEUVIMED entdecken
Crossref

Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients

Francesca La Gualana, Giulio Olivieri, Begi Petriti, Licia Picciariello, Francesco Natalucci, Maddalena Sciannamea, Laura Gragnani, Umberto Basile, Milvia Casato, Francesca Romana Spinelli, Lucia Stefanini, Stefania Basili und 3 weitere

Immunology Letters · 2025

DOI: 10.1016/j.imlet.2024.106962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology Letters, 2025. Verfasst von Francesca La Gualana und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational and Precision Medicine, Sapienza University, Rome, Italy. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Antibodies, Monoclonal, Humanized, T-Box Domain Proteins, B-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, NextGenerationEU, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicAntibodies, Monoclonal, HumanizedT-Box Domain ProteinsB-LymphocytesImmunosuppressive AgentsHumansFemaleAdultMaleMiddle AgedT-bet Transcription FactorInjections, SubcutaneousTreatment OutcomeBiomarkersImmunophenotyping

Stichwörter der Autor:innen

BelimumabBiomarkerSystemic lupus erythematosusT-bet(+) B cells

Substanzen

belimumabAntibodies, Monoclonal, HumanizedT-Box Domain ProteinsT-bet Transcription FactorImmunosuppressive AgentsBiomarkers

Autor:innen und Institutionen

  • Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome.
  • Lupus Clinic, Rheumatology, Dipartimento di Scienze Cliniche Internistiche Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Viale del Policlinico 155 00161 Rome, Italy.
  • Department of Translational Research and New Technologies in Medicine and Surgery, Medical School, University of Pisa, Pisa, Italy.
  • Department of Clinical Pathology, Santa Maria Goretti HospitalAUSL Latina, Latina, Italy.
  • Department of Translational and Precision Medicine, Sapienza University, Rome, Italy. Electronic address: marcella.visentini@uniroma1.it.

Förderung

  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • NextGenerationEU
  • European Commission
  • Sapienza Università di Roma

Zitieren

APA

La Gualana, F., Olivieri, G., Petriti, B., Picciariello, L., Natalucci, F., Sciannamea, M., Gragnani, L., Basile, U., Casato, M., Spinelli, F. R., Stefanini, L., Basili, S., Visentini, M., Ceccarelli, F., & Conti, F. (2025). Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients. Immunology Letters. https://doi.org/10.1016/j.imlet.2024.106962

Vancouver

La Gualana F, Olivieri G, Petriti B, Picciariello L, Natalucci F, Sciannamea M, et al. Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients. Immunology Letters. 2025. doi:10.1016/j.imlet.2024.106962

BibTeX
@article{LaGualana2025,
  author = {La Gualana, Francesca and Olivieri, Giulio and Petriti, Begi and Picciariello, Licia and Natalucci, Francesco and Sciannamea, Maddalena and Gragnani, Laura and Basile, Umberto and Casato, Milvia and Spinelli, Francesca Romana and Stefanini, Lucia and Basili, Stefania and Visentini, Marcella and Ceccarelli, Fulvia and Conti, Fabrizio},
  title = {Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients},
  journal = {Immunology Letters},
  year = {2025},
  doi = {10.1016/j.imlet.2024.106962}
}
Kostenlos starten →